Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
232 USD | -2.00% | +5.42% | -10.35% |
06/06 | US FDA panel to vote on data, risk profile of Lilly Alzheimer's drug | RE |
06/06 | Wedbush Adjusts Price Target on Biogen to $215 From $219 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.35% | 33.78B | |
+0.82% | 93.19B | |
0.00% | 39.62B | |
+65.15% | 26.82B | |
-16.15% | 15.35B | |
-6.98% | 13.13B | |
-11.77% | 11.6B | |
-49.19% | 10.26B | |
+5.39% | 9.43B | |
+141.62% | 9.26B |
- Stock Market
- Equities
- BIIB Stock
- News Biogen Inc.
- Biogen to Buy Reata Pharmaceuticals for $172.50/Share in Cash; Deal Completion Anticipated in Q4